Biomarker-based prognosis in hepatocellular carcinoma: validation and extension of the BALAD model

Prognostic importance of fucosylated alpha-fetoprotein in hepatocellular carcinoma patients with low alpha-fetoprotein

(2011) Kazuhiro Nouso et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Report of the 18th follow-up survey of primary liver cancer in Japan

(2010) Iwao Ikai et al.   HEPATOLOGY RESEARCH

Advanced Hepatocellular Carcinoma: Which Staging Systems Best Predict Prognosis?

(2010) Fidel-David Huitzil-Melendez et al.   JOURNAL OF CLINICAL ONCOLOGY

Prospective validation of the Chinese University Prognostic Index and comparison with other staging systems for hepatocellular carcinoma in an Asian population

(2010) Stephen L Chan et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Automated immunoassay system for AFP–L3% using on-chip electrokinetic reaction and separation by affinity electrophoresis

(2009) Chiaki Kagebayashi et al.   ANALYTICAL BIOCHEMISTRY

Applicability of staging systems for patients with hepatocellular carcinoma is dependent on treatment method – Analysis of 2010 Taiwanese patients

(2009) Chien-Hung Chen et al.   EUROPEAN JOURNAL OF CANCER

Prognosis of advanced hepatocellular carcinoma: comparison of three staging systems in two French clinical trials

(2008) S. Collette et al.   ANNALS OF ONCOLOGY

Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization

(2007) Yun Ku Cho et al.   CANCER